Patient guide
What monitoring involves when you take a GLP-1 medicine
Starting a GLP-1 medicine is not a single appointment. Safe prescribing involves follow-up on weight, side effects, hydration, blood tests where relevant and the decision to continue or stop. This guide sets out what that monitoring usually looks like.
Last checked: 2026-10-03
Key facts
At a glance.
-
Dose steps
Most products rise through several dose levels. A check-in at each step helps catch side effects before the dose goes up again.
-
What to measure
Weight trend, waist, blood pressure, side effects, food and fluid intake, mood and, in people with diabetes, glucose control.
-
Blood tests
Not universal, but common where there is diabetes, kidney or liver disease, or when other medicines are being adjusted.
-
Stopping rule
A good plan states in advance what level of response justifies continuing and what leads to stopping.
Why monitoring matters
These medicines change appetite, digestion and, in people with diabetes, blood glucose. They are usually well tolerated but can cause dehydration, gastrointestinal upset and, rarely, serious problems such as pancreatitis or gallbladder disease. Monitoring is how a prescriber checks that benefit outweighs harm for you personally, rather than assuming it does.
A typical review schedule
There is no single national schedule, and services vary. The table below describes a common pattern so you can judge whether the follow-up you are offered is reasonable.
| When | What is usually discussed |
|---|---|
| Before starting | History, medicines, pregnancy plans, baseline weight and blood pressure, relevant blood tests. |
| Each dose increase | Nausea, bowel changes, reflux, appetite, fluid intake, any abdominal pain. |
| At the stage the licence recommends | Whether the response justifies continuing at the current dose. |
| Ongoing | Weight trend, nutrition, mood, other medicines, plans for maintenance or stopping. |
What you can monitor at home
Weigh yourself at a consistent time and look at the trend over weeks, not day-to-day movement. Keep a simple note of side effects, what you are eating and drinking, and any days when you could not keep food down. Take your blood pressure if you have a home monitor and have been asked to. If you have diabetes and use glucose-lowering medicines, follow the advice you have been given about checking glucose, because the combination can cause low blood sugar, particularly with insulin or sulfonylureas.
Blood tests and what they look for
A prescriber may check kidney function because vomiting and diarrhoea can cause dehydration that stresses the kidneys. They may check HbA1c to see how glucose control is changing, lipid levels to track cardiovascular risk, and liver tests in people with fatty liver disease. Where a person has had significant weight loss, a prescriber may also consider iron, vitamin B12 and vitamin D if there are symptoms or dietary restriction.
Signs that should prompt contact
Contact your prescriber or NHS 111 promptly for persistent vomiting or inability to keep fluids down, severe or persistent abdominal pain, particularly if it spreads to the back, yellowing of the skin or eyes, signs of an allergic reaction, or marked low mood or distressing thoughts about food or self-harm. Severe pain with vomiting is an emergency and needs urgent assessment through 999 or A&E.
Reporting side effects
You can report suspected side effects to the MHRA through the Yellow Card scheme, either yourself or through a health professional. Reports help the regulator identify patterns and update safety advice. Keep the product name and batch number, which are printed on the pen or packaging.
Frequently asked
Questions people ask.
Quick, plain-English answers to the questions we hear most.
-
How often should I be reviewed?
It depends on the service and the dose schedule, but you should have contact at each dose change and a planned review of response, not just a repeat supply.
-
Do I need a blood test before every prescription?
No. Tests are guided by your history and risks. Ask why they are being requested or not.
-
Should my blood pressure be checked?
Weight loss often lowers blood pressure, and people on antihypertensives may need a dose review. A baseline and follow-up readings are sensible.
-
What if I am losing weight very quickly?
Discuss it with your prescriber. Rapid loss can indicate you are not eating enough, increase gallstone risk and affect muscle mass.
-
Does monitoring include my mental health?
It should include a conversation about mood and eating patterns, particularly if you have a history of disordered eating or depression.
-
Can my GP do the monitoring?
Some do, many do not take on monitoring for privately started treatment. Agree responsibility at the outset.
-
What if I take contraceptive pills?
Product information for at least one tirzepatide medicine advises extra contraceptive precautions at start and after dose increases. Ask your prescriber what applies to you.
-
Is there monitoring after I stop?
A follow-up about weight, appetite and eating patterns after stopping is good practice, because regain is common and support helps.
Where this comes from
Sources and checking.
This guide is for information, not medical advice.
Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.
Published 2026-10-03, next review 2027-10-03.
-
NICE guideline NG246, Overweight and obesity management (nice.org.uk)
-
MHRA drug safety updates and Yellow Card scheme information (gov.uk/mhra)
-
NHS website, Obesity and weight-loss medicines pages (nhs.uk)
-
General Medical Council, Good practice in prescribing and managing medicines and devices (gmc-uk.org)